Targeting PI3K in neuroblastoma

被引：0
|
作者：
Volker Spitzenberg
Christian König
Susanne Ulm
Romina Marone
Luise Röpke
Jörg P. Müller
Michael Grün
Reinhard Bauer
Ignacio Rubio
Matthias Paul Wymann
Astrid Voigt
Reinhard Wetzker
机构：
[1] Jena University Hospital,Department of Molecular Cell Biology, Center for Molecular Biomedicine
[2] Jena University Hospital,Childrens Hospital
[3] University of Basel,Institute of Biochemistry and Genetics, Department for Biomedicine
来源：
Journal of Cancer Research and Clinical Oncology | 2010年 / 136卷
关键词：
Neuroblastoma; PI3K; AS605240; Apoptosis; Tumor; Target;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1881 / 1890
页数：9
相关论文
共 50 条
  • [31] The Role of PI3kγ and PI3kΔ in Alloimmunity
    Uehara, M.
    Jamil, A.
    Solhjou, Z.
    McGrath, M.
    Banouni, N.
    Evans, C.
    Dinitto, J.
    Winkler, D.
    Abdi, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 325 - 325
  • [32] The role of PI3kγ and PI3kδ in alloimmunity
    Uehara, Mayuko
    Jamil, Azzi
    Ohori, Shunsuke
    Solhjou, Zhabiz
    McGrath, Martina
    Banouni, Naima M.
    Evans, Catherine A.
    Dinitto, Jonathan P.
    Winkler, David G.
    Abdi, Reza
    TRANSPLANTATION, 2016, 100 (07) : S361 - S361
  • [33] Regulation of PI3K signaling in cancer metabolism and PI3K-targeting therapy
    Han, Beinan
    Lin, Xiaorong
    Hu, Hai
    TRANSLATIONAL BREAST CANCER RESEARCH, 2024, 5
  • [34] The PI3K signalling pathway modulates the hypoxia response in neuroblastoma
    Bridges, Esther
    Beckmann, Claudia
    Akerblom, Malin
    Pahlman, Sven
    CANCER RESEARCH, 2009, 69
  • [35] The PI3K/Akt/mTOR Pathway as Therapeutic Target in Neuroblastoma
    Fulda, S.
    CURRENT CANCER DRUG TARGETS, 2009, 9 (06) : 729 - 737
  • [36] Targeting Aberrant PI3K/Akt Activation by PI103 Restores Sensitivity to TRAIL-Induced Apoptosis in Neuroblastoma
    Opel, Daniela
    Naumann, Ivonne
    Schneider, Maxi
    Bertele, Daniela
    Debatin, Klaus-Michael
    Fulda, Simone
    CLINICAL CANCER RESEARCH, 2011, 17 (10) : 3233 - 3247
  • [37] Targeted molecular therapy of the PI3K pathway - Therapeutic significance of PI3K subunit targeting in colorectal carcinoma
    Rychahou, Piotr G.
    Jackson, Lindsey N.
    Silva, Scott R.
    Rajaraman, Srinivasan
    Evers, B. Mai
    ANNALS OF SURGERY, 2006, 243 (06) : 833 - 844
  • [38] Development of single and mixed isoform selectivity PI3Kδ inhibitors by targeting Asn836 of PI3Kδ
    Miller, Michelle S.
    Mountford, Simon J.
    Pinson, Jo-Anne
    Zheng, Zhaohua
    Kunzli, Marco
    Patel, Vanit
    Hogg, Simon J.
    Shortt, Jake
    Jennings, Ian G.
    Thompson, Philip E.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (19) : 4790 - 4794
  • [39] Targeting PI3K in cancer: any good news?
    Martini, Miriam
    Ciraolo, Elise
    Gulluni, Federico
    Hirsch, Emilio
    FRONTIERS IN ONCOLOGY, 2013, 3
  • [40] Prodrug targeting PI3K shows therapeutic potential
    Legg K.
    Nature Reviews Rheumatology, 2009, 5 (10) : 526 - 526
12345